🇺🇸 Insulin Regular in United States
510 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 510
Most-reported reactions
- Acute Kidney Injury — 68 reports (13.33%)
- Pneumonia — 60 reports (11.76%)
- Blood Glucose Increased — 56 reports (10.98%)
- Dyspnoea — 50 reports (9.8%)
- Nausea — 48 reports (9.41%)
- Asthenia — 47 reports (9.22%)
- Hypoglycaemia — 46 reports (9.02%)
- Pain — 46 reports (9.02%)
- Vomiting — 45 reports (8.82%)
- Malaise — 44 reports (8.63%)
Other Diabetes approved in United States
Frequently asked questions
Is Insulin Regular approved in United States?
Insulin Regular does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Insulin Regular in United States?
The University of Texas Medical Branch, Galveston is the originator. The local marketing authorisation holder may differ — check the official source linked above.